Drugmaker stocks gained a temporary reprieve on Thursday as U.S. President Donald Trump spared pharmaceutical products from ...
Meanwhile, the Nifty Pharma index saw all 20 of its constituents trading in the red. Stocks such as Biocon, IPCA Laboratories ...
Pharma stocks nosedive as US tariff fears spook investors. Nifty Pharma sinks 6%, with Gland Pharma and Divi’s Labs falling ...
Pharma stocks rise as Trump exempts pharmaceuticals from reciprocal tariffs. Indian, UK, and Japanese drugmakers gain.
Benchmark indices closed in the red after US President Donald Trump announced sweeping reciprocal tariffs on a number of ...
Perhaps the Tuesday pharma sell-off was mitigated by indications Trump and his team might be amenable to either a softer or more gradual approach to industry tariffs. That bearishness about the ...
European healthcare stocks tumble as Trump prepares new tariffs, with pharmaceutical firms bracing for economic fallout and market uncertainty.
Tivoxavir marboxil’s potential as a single dose therapeutic agent for bird flu supported by significant antiviral activity in three well accepted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results